课题基金 / 基金详情

Research Training in Pulmonary Immunology and Allergy at Massachusetts General Hospital

Research Training in Pulmonary Immunology and Allergy at Massachusetts General Hospital
马萨诸塞州总医院肺部免疫学和过敏研究培训
批准号:
10713582
负责人:
David C Christiani
金额:
$72.13万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-07-01 至 2028-06-30

项目摘要

项目成果

David C Christiani的其他基金

相似基金

相关文献

中文摘要
翻译
MGH的肺免疫学和过敏研究培训是T32更新申请,带来了
英文摘要
Research Training in Pulmonary Immunology and Allergy at MGH is a T32 renewal application that brings together research programs of the Massachusetts General Hospital (MGH) Division of Pulmonary and Critical Care Medicine (DPCCM), Allergy and Clinical Immunology Unit (ACIU), and Center for Immunology and Inflammatory Diseases. This Training Program was created principally to provide comprehensive training for physician-scientists in the DPCCM and ACIU fellowship programs interested in lung immunology and allergic inflammation. The Program is designed to prepare the next generations of physician-scientists and PhD- scientists to be leaders in lung immunology and allergy related research. In the first 9 years, this Program has been highly successful with no unfilled slots and 100% rate of retention in academic centers or in industry research. In addition, all but one former trainee who finished their T32 support more than 3 years ago have published first author papers and submitted grant applications, and 50 research grants have been awarded. In this renewal application we capitalize on this success and momentum and provide training in 12 scientific disciplines: (i) Adaptive Lung Immunity; (ii) Innate Lung Immunity; (iii) Allergic Sensitization, Tolerance & Immunodeficiency; (iv) Lung Injury, Repair & Regeneration; (v) Molecular Epidemiology & Genetics of Lung Disease and Allergy; (vi) Health Care Delivery Science in Pulmonary and Allergy; (vii) Translational & Precision Medicine; (viii) Systems Biology, Single Cell Genomics & Epigenetics; (ix) Microbiome; (x) Novel Imaging Modalities; (xi) Metabolism; (xii) and Nanotechnology and Organoids. The Program will have basic, translational, health outcomes and epidemiology components. Specifically, we seek to provide: 1) opportunities for mentored research in disciplines that have the potential for high-impact discoveries; 2) outstanding research training through didactics, seminars, and comprehensive mentoring; and 3) an environment and infrastructure that fosters scholarly activity and career development into independent scientists. This application requests a continuation of 8 training positions that will be allocated to trainees who are committed to 2 to 3 years of research training. MD or MD/PhD candidates will be drawn from the DPCCM and ACIU fellowship programs. PhD trainees will be chosen from postdoctoral fellows in the mentor laboratories who have demonstrated a commitment to careers in pulmonary or allergy research. The 33 mentors (12 women, 4 underrepresented minorities in medicine) in this Program were carefully chosen based on their track record of publications, grants, mentoring, collaboration and interest in lung immunology and allergy. MGH provides an outstanding scientific and training environment for its over 2,000 investigators and thousands of trainees with numerous training grants, research centers, trainee support groups and over $1.2 billion in research grant awards. Furthermore, opportunities at the nearby Harvard Medical School, the Harvard Chan School of Public Health, the Broad Institute, the Ragon Institute and Massachusetts Institute of Technology provide additional valuable resources for trainees.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
Emergency department revisits and rehospitalizations among infants and toddlers for acute allergic reactions.
急诊科对婴儿和幼儿因急性过敏反应进行重新检查和再住院。
DOI: 10.2500/aap.2021.42.210031
发表时间: 2021
期刊: Allergy and asthma proceedings
影响因子: 2.8
作者: [Robinson,LaceyB, Arroyo,AnnaChen, Cash,RebeccaE, Rudders,SusanA, CamargoJr,CarlosA]
通讯作者: CamargoJr,CarlosA
DOI: 10.1093/ofid/ofac499
发表时间: 2022-10
期刊: OPEN FORUM INFECTIOUS DISEASES
影响因子: 4.2
作者: [Li, Jennifer Chen, Siglin, Jonathan, Marshall, Michael S., Stemmer-Rachamimov, Anat, Bloom, Seth M., Blumenthal, Kimberly G.]
通讯作者: Blumenthal, Kimberly G.
Aetiology of hospitalized fever and risk of death at Arua and Mubende tertiary care hospitals in Uganda from August 2019 to August 2020.
2019年8月至2020年8月,乌干达的Arua和Mubende Tertriary Care Hospitals的病因和死亡风险。
DOI: 10.1186/s12879-022-07877-3
发表时间: 2022-11-21
期刊: BMC INFECTIOUS DISEASES
影响因子: 3.7
作者: [Blair, Paul W., Kobba, Kenneth, Kakooza, Francis, Robinson, Matthew L., Candia, Emmanuel, Mayito, Jonathan, Ndawula, Edgar C., Kandathil, Abraham J., Matovu, Alphonsus, Aniku, Gilbert, Manabe, Yukari C., Lamorde, Mohammed]
通讯作者: Lamorde, Mohammed
DOI: 10.1155/2014/910215
发表时间: 2014
期刊: Case reports in immunology
影响因子: 1
作者: [Farmer JR, Sokol CL, Bonilla FA, Murali MR, Kradin RL, Astor TL, Walter JE]
通讯作者: Walter JE
23
    Harvard TH Chan Education and Research Center for Occupational Safety and Health
    • 批准号:
      10762715
    • 项目类别:
    • 资助金额:
      $138.18万
    • 财政年份:
      2023
    • 负责人:
      David C Christiani
    • 依托单位:
    OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42)
    • 批准号:
      10456000
    • 项目类别:
    • 资助金额:
      $160.61万
    • 财政年份:
      2018
    • 负责人:
      David C Christiani
    • 依托单位:
    Multi-Pathway DNA Repair Capacity Measurements in Lung Cancer Patients and Healthy Controls
    • 批准号:
      10447766
    • 项目类别:
    • 资助金额:
      $60.12万
    • 财政年份:
      2018
    • 负责人:
      David C Christiani
    • 依托单位:
    OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42)
    • 批准号:
      9794128
    • 项目类别:
    • 资助金额:
      $168.6万
    • 财政年份:
      2018
    • 负责人:
      David C Christiani
    • 依托单位:
    海外基金